PALVELLA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense in USD from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Palvella Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to Q3 2025.
  • Palvella Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $1.79M, a 799% increase year-over-year.
  • Palvella Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $4.59M.
  • Palvella Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $830K, a 37.6% increase from 2023.
  • Palvella Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $603K, a 86.3% decline from 2022.
  • Palvella Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.4M, a 15.6% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

PALVELLA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.59M $1.79M +$1.59M +799% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $2.99M $1.43M +$1.22M +560% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $1.78M $1.09M +$948K +649% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $830K $268K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $199K Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $217K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $146K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2017 $3.05M $1.08M +$605K +126% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $2.44M $650K +$204K +45.7% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $2.24M $560K -$52K -8.49% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $2.29M $752K +$384K +104% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $1.91M $479K +$137K +40.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $1.77M $446K +$108K +32.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $1.66M $612K +$344K +128% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $1.32M $368K +$151K +69.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.16M $341K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $338K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $268K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $217K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12

PALVELLA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $830K +$227K +37.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $603K -$3.8M -86.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $4.4M -$813K -15.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $5.22M +$125K +2.46% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $5.09M -$284K -5.29% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $5.37M +$431K +8.72% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $4.94M +$1.9M +62.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $3.05M +$1.14M +59.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $1.91M +$740K +63.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $1.16M +$593K +104% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $571K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.